OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Inside the Billionaires’ Club: The 8 Richest CEOs in the World

Inside the Billionaires’ Club: The 8 Richest CEOs in the World

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

AMD stock slumps 7% on earnings miss, China AI chip concerns

Super Micro stock sinks 20% after earnings, outlook disappoint

Shopify stock soars 20% on rosy guidance as CFO says tariff hit ‘did not materialize’

Uber beats on revenue, announces $20 billion stock buyback

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Return Trends At PayPal Holdings (NASDAQ:PYPL) Aren’t Appealing

October 22, 2022

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is... Read More...

3rdPartyFeeds

Netflix Stock Soars After Ending Streak of Subscriber Losses: Does That Make Netflix Stock a Buy?

October 22, 2022

After two consecutive quarters of subscriber losses, Netflix (NASDAQ: NFLX) ended the horrible streak by adding over 2 million subscribers in its most recent...

3rdPartyFeeds

The Big Banks Kick Off Earnings Season for Investors

October 22, 2022

Plus, CNBC's Bob Pisani shares investing insights from 25 years on the floor of the New York Stock Exchange. Read More...

3rdPartyFeeds

Netflix Just Unlocked a $10 Billion Revenue Opportunity. Can it Take Advantage?

October 22, 2022

Netflix (NASDAQ: NFLX) shares surged Wednesday after the streaming leader beat subscriber expectations in its third quarter and guided for subscriber additions...

3rdPartyFeeds

Bear Market Investing: Should You Really Buy Retail Stocks Right Now?

October 22, 2022

The SPDR S&P Retail ETF has dropped 36% this year. With this in mind, should you really invest in retail stocks right now? E-commerce giant Amazon (NASDAQ:...

3rdPartyFeeds • News

: The ‘pandemic boom markets’ where home price growth is slowing the most

October 22, 2022

Housing markets across the country are seeing home price growth slow, led by Sacramento, Calif., according to a new report by First American.
Read More...

3rdPartyFeeds

Amazon Tells Staff to ‘Double Down on Frugality.’ Should You?

October 22, 2022

Amazon is tightening its belt as economic troubles around the world and rumors of a possible recession start to impact its business. Frugality has always been...

3rdPartyFeeds

Meta-backed Meesho is Beating Amazon, Walmart in Race for Indian Shoppers

October 22, 2022

The upstart e-commerce service is posing a challenge to the U.S. retailing titans, which have plowed billions of dollars into the world’s biggest untapped...

3rdPartyFeeds

Chinese Chip Startup Shows Key Gap in Biden Export Curbs

October 22, 2022

(Bloomberg) -- One of China’s most promising chip designers has already navigated through the Biden administration’s export restrictions and concluded it will...

3rdPartyFeeds

Republican National Committee sues Google over email spam filters

October 22, 2022

The U.S. political committee accuses the tech giant of "discriminating" against it by "throttling its email messages because of the RNC’s political affiliation...

Previous 1 … 2,085 2,086 2,087 2,088 2,089 … 8,328 Next
Indices by TradingView
Inside the Billionaires’ Club: The 8 Richest CEOs in the World

Inside the Billionaires’ Club: The 8 Richest CEOs in the World

August 6, 2025
Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

August 6, 2025

AMD stock slumps 7% on earnings miss, China AI chip concerns

August 6, 2025

Super Micro stock sinks 20% after earnings, outlook disappoint

August 6, 2025

Shopify stock soars 20% on rosy guidance as CFO says tariff hit ‘did not materialize’

August 6, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.